GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. (Q2905968)

From EU Knowledge Graph
Revision as of 15:06, 13 September 2021 by DG Regio (talk | contribs) (‎Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal)
Jump to navigation Jump to search
Project Q2905968 in Portugal
Language Label Description Also known as
English
GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies.
Project Q2905968 in Portugal

    Statements

    0 references
    166,566.0 Euro
    0 references
    1 July 2016
    0 references
    31 December 2019
    0 references
    IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
    0 references
    Q2993205 (Deleted Item)
    0 references

    Identifiers

    POCI-01-0145-FEDER-016601
    0 references